Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability

European Journal of Nuclear Medicine

Volumn 26, Issue 4, 1999, Pages 416-424

  Delahaye, Nicolas ^a   Dinanian, Sylvie ^b   Slama, Michel S ^b   Mzabi, Hichem ^c   Samuel, Didier ^c   Adams, David ^d   Merlet, Pascal ^e   Le Guludec, Dominique ^a  

^a BICHAT HOSPITAL   (France)

^b A Béclère Hospital   (France)

^c P Brousse Hospital   (France)

^d BICÊTRE HOSPITAL   (France)

^e DIF   (France)

Author keywords

Autonomic nervous system; Familial amyloid polyneuropathy; Heart rate variability; Metaiodobenzylguanidine

Indexed keywords

(3 IODOBENZYL)GUANIDINE; AMYLOID; IODINE 123; PREALBUMIN; THALLIUM;

ADRENERGIC SYSTEM; ADULT; AMYLOID NEUROPATHY; ANGIOCARDIOGRAPHY; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GENETIC VARIABILITY; HEART DENERVATION; HEART LEFT VENTRICLE FUNCTION; HEART PERFUSION; HEART RATE VARIABILITY; HUMAN; LIVER; LIVER TRANSPLANTATION; MALE; NORMAL HUMAN; RADIOISOTOPE VENTRICULOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SYSTOLE;

3-IODOBENZYLGUANIDINE; ADULT; AGED; AMYLOID NEUROPATHIES; CATECHOLAMINES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DENERVATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART RATE; HUMANS; MALE; MIDDLE AGED; RADIONUCLIDE VENTRICULOGRAPHY; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0032916634     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050406     Document Type: Article

References (50)

1. 1. Andrade C. A peculiar form of peripheral neuropathy: familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408-427.
2. 2. Saraiva MJM, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type: definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984; 74: 104-119.
3. 3. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys MB. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341: 1113-1116.
4. 4. Parrilla P, Lopez-Andreu FR, Ramirez P, Bueno FS, Robles R, Miras M, Escribano JB, Vicente J, Acosta F, Munar Ques M, Costa PP, Teixera A. Familial amyloidotic polyneuropathy type I (Andrade's disease): a new indication for liver transplant. Transplantation 1994; 57: 473-475.
5. 5. Suhr OB, Holmgren G, Steen L, Wikström L, Norden G, Friman S, Duraj FF, Groth CG, Ericzon BG. Liver transplantation in familial amyloidotic polyneuropathy. Transplantation 1995; 60: 933-938.
6. 6. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996; 47: 944-951.
7. 7. Coelho E, Pimentel JC. Cardiac involvement in a peculiar form of paramyloidosis. Am J Cordial 1961; 8: 624-632.
8. 8. Falcao de Freitas A. The heart in portuguese amyloidosis. Postgrad Med J 1986; 62: 601-605.
9. 9. Eriksson P, Karp K, Bjerle P, Olofsson BO. Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J 1984; 51: 658-662.
10. 10. Olofsson BO, Andersson R, Furberg B. Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand 1980; 208: 77-80.
11. 11. Bergfeldt BL, Olofsson BO, Edhag KO. Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. Am J Cardiol 1985; 56: 647-652.
12. 12. Roberts WC, Waller BF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 1983; 52: 137-146.
13. 13. Takahashi K, Yi S, Kimura Y, Araki S. Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Hum Pathol 1991; 22: 519-527.
14. 14. Eriksson A, Eriksson P, Olofsson BO, Thornell LE. The cardiac atrioventricular conduction system in familial amyloidosis wih polyneuropathy. A clinico-pathologic study of six cases from northern Sweden. Acta Pathol Microbiol Immunol Scand, Sect A 1983; 91: 343-349.
15. 15. Niklasson U, Olofsson BO, Bjerle P. Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability. Acta Neurol Scand 1989; 79: 182-187.
16. 16. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, Glowniak JV, Sherman P, Beierwaltes BS and WH. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28: 1625-1636.
17. 17. Khafagi FA, Shapiro B, Fig. LM, Mallette S, Sisson JC. Labe-talol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 1989; 30: 481-489.
18. 18. Merlet P, Valette H, Dubois-Randé JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D, Loisance D, Castaigne A, Syrota A. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477.
19. 19. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492.
20. 20. Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-381.
21. 21. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995; 91: 1936-1943.
22. 22. Tobes MC, Jaques S Jr, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1985; 26: 897-907.
23. 23. Dae MW, De Marco T, Botvinick EH, O'Connel JW, Hattner RS, Huberty JP, Yuen-Green MS. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - implications for clinical studies. J Nucl Med 1992; 33: 1444-1450.
24. 24. Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P, Shinohara S. Iodine-131 metaiodobenzylguanidine intra-and extravesicular accumulation in the rat heart. J Nucl Med 1986; 27: 84-89.
25. 123I]iodobenzylguanidine in isolated rat heart. Nucl Med Biol 1995; 22: 1-12.
26. 26. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, Ugolini V, Akers MS, Hansen C, Buja LM, Parkey RW, Willerson JT. Abnormal I-123 metaiodobenzylguanidine cardiac washout and distribution may reflect cardiac adrenergic derangement in patients with congestive cardiomyopathy. Circulation 988; 78: 1192-1199.
27. 27. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, Fukuyama T. Iodine-123 metaiodobenzylguanidine images reflect intense cardiac adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 1995; 26: 1594-1599.
28. 28. Nakata T, Shimamoto K, Yonekura S, Kobayashi N, Sugiyama T, Imai K, Limura O. Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG. J Nucl Med 1995; 36: 1040-1042.
29. 29. Tanaka M, Kongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, Isobe M, Sekiguchi M. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of cardiac sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 1997; 29: 168-174.
30. 30. Nakata T, Nagao K, Tsuchihashi K, Hashimoto A, Tanaka S, Limura O. Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine tomography in stable coronary artery disease. Am J Cardiol 1996; 78: 292-297.
31. 31. Tsutsui H, Ando S, Fukai T, Kuroiwa M, Egashira K, Sasaki M, Kuwabara Y, Koyanagi S, Takeshita A. Detection of angina-provoking coronary stenosis by resting iodine 123 metaiodobenzylguanidine scintigraphy in patients with unstable angina pectoris. Am Heart J 1995; 129: 708-715.
32. 32. Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent cardiac ischemia. J Am Coll Cardiol 1995; 25: 610-618.
33. 123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function. Diabetes 1995; 44: 543-549.
34. 34. Said G, Ropert A, Faux N. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: a clinicopathologic study. Neurology 1984; 34: 1025-1032.
35. 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Diabet Med 1996; 13: 266-272.
36. 123I]metaiodobenzylguanidine. Diabetes 1992; 41: 1069-1075.
37. 37. Wei K, Dorian P, Newman D, Langer A. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 1995; 26: 859-863.
38. 38. Kim SJ, Lee JD, Ryu YH, Jeon P, Shim YW, Yoo HS, Park CY, Lim SG. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Eur J Nucl Med 1996; 23: 401-406.
39. 39. Freeman MR, Newman D, Dorian P, Barr A, Langer A. Relation of direct assessment of cardiac autonomic function with metaiodobenzylguanidine imaging to heart rate variability in diabetes mellitus. Am J Cardiol 1997; 80: 247-250.
40. 40. Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, Tsujimura E, Ito Y, Hori M, Kamada T, Nishimura T. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997; 38: 49-52.
41. 41. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989; 30: 1182-1991.
42. 42. Rabinovitch MA, Rose CP, Schwab AJ, Fitchett DH, Honos GN, Stewart JA, Chen LF, Castilla EP, Gomez AA, Abrahamowicz M. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993; 34: 589-600.
43. 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 1994; 15: 317-323.
44. 44. Alexopoulos D, Yusuf S, Johnston JA, Bostock J, Sleight P, Yacoub MH. The 24-hour heart rate behavior in long-term survivors of cardiac transplantation. Am J Cordial 1988; 61: 880-884.
45. 45. Abe M, Ando Y, Higashi K, Kano T. Non-neurogenic periodic fluctuations in heart rate and vasomotion appearing in familial amyloid polyneuropathy (FAP) type I (Met30). J Auton Nerv Syst 1996; 60: 71-75.
46. 46. Ikeda S, Yanagisawa N, Kongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci 1987; 79: 129-139.
47. 47. Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, Suga M, Uchino M, Ando M. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 1995; 345: 195-196.
48. 48. Hartikainen J, Kuikka J, Mäntysaari M, Länsimies E, Pyörälä K. Sympathetic reinnervation after acute cardiac infarction. Am J Cardiol 1996; 77: 5-9.
49. 49. De Marco T, Dae M, Yuen-Green MSF, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D, Botvinick EH, Chatterjee K. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cordial 1995; 25: 927-931.
50. 50. Schnell O, Muhr D, Dresel S, Weiss M, Haslbeck M, Standl E. Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type I) diabetes mellitus at one-year follow-up. Diabet Med 1997; 14: 57-62.